United States
Apr 27, 2021
Robbins, R.N., Kluisza, L., Liu, J. et al. Construct Validity Supports Use of a Novel, Tablet-Based Neurocognitive Assessment for Adolescents and Young Adults Affected by Perinatal HIV from Vulnerable Communities in the United States. AIDS Behav 25, 1185–1191 (2021)....
Feb 17, 2021
Ezer Kang, Claude A Mellins, Woojae Kim, Curtis Dolezal, Christine Kindler, Cheng-Shiun Leu, Elaine J Abrams AIDS and Behavior (2021) doi: https://doi.org/10.1007/s10461-021-03166-3 Abstract Perceived HIV stigma and mental health are fluid across the lifespan for...
Dec 4, 2020
RECORDED: Tuesday, November 10, 2020, 9:00 AM – 10:00 AM An effective and safe COVID-19 vaccine is anxiously anticipated by millions of people around the world. A total of 12 vaccines are currently in Phase III (large scale) clinical trials around the globe. In...
Dec 4, 2020
RECORDED: Thursday, December 3, 2020, 10:00 AM – 11:30 AM Keynote by Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases. Presentation: Resilience and Innovation: Mitigating the Impact of COVID-19 on HIV Programs by Miriam...
Nov 16, 2020
R N Robbins, L Kluisza, J Liu, A F Santoro, J Raymond, N Ngyuen, S Espinel, E Siegel, C Dolezal, A Wiznia, E J Abrams, C A Mellins PMID: 33180252 DOI: 10.1007/s10461-020-03099-3 Abstract Construct validity of novel tablet-based neurocognitive tests (in the NeuroScreen...
